Based on the PPI network analysis and four algorithms in Cytoscape software, STAT3, JUN, MAPK3, TP53, MAPK1, RELA, FOS, ESR1, IL6, MAPK14, MYC, and CDKN1A were identified as hub targets in the treatment of CRC. Here, TP53 is linked to colorectal carcinoma.